2009 Chemical and Biological Terrorism Defense Gordon Research Conference

2009年化学和生物恐怖主义防御戈登研究会议

基本信息

  • 批准号:
    7608881
  • 负责人:
  • 金额:
    $ 1.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-12-15 至 2009-11-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This proposal requests partial support for the 2009 Chemical and Biological Terrorism Defense Gordon Research Conference, to be held in Galveston, TX, January 18 - 23, 2009. The broad and long term goal of the conference, as embodied in the theme for 2009, is Integrating "Everyday" with "Maybe Someday". There are numerous challenges in developing defenses, particularly medical countermeasures, or detection systems, to address biological or chemical threats. This Conference will focus on an array of topics in which new research has been focused on broad spectrum and platform technology approaches to discovering and developing defenses for biological and chemical threats that both leverage and integrate "everyday" applications. The specific aims of this meeting will be to convene a total of 135 participants, of which it is anticipated that 54 will be speakers, to represent new and critical areas of research that will be needed to allow the "leap ahead" in new approaches to integrating preparedness for the health impacts of chemical or biological terrorism with "everyday" technologies and systems for medicine, public health, and acute environmental hazards. The program will have a keynote address session and eight scientific sessions that address broad spectrum therapeutics, platform technologies for diagnostics, integration of chemical and biological detection into general use platforms; early host responses to biological and chemical agents; translational research: animals to people; "magic bullets": immunomodulators and immune enhancers; "OMICS" for biological and chemical agents; and screening strategies: targets and opportunities for intervention. In addition to the oral presentations, ample opportunities for poster sessions will be provided. The significance of this application is that the Gordon Research Conference on Chemical and Biological Terrorism Preparedness provides a unique opportunity for close interaction and exchange of research information among allergic process researchers in this somewhat "niche" area. The health relatedness of this application is that the ultimate goal of research in chemical and biological terrorism defense is to provide new opportunities for health interventions, whether they be drugs, vaccines, diagnostics, or detection systems, to help protect the population of the United States in the event of a terrorism attack with these agents.
说明(由申请人提供):本提案请求部分支持 2009 年化学和生物恐怖主义防御戈登研究会议,该会议将于 2009 年 1 月 18 日至 23 日在德克萨斯州加尔维斯顿举行。会议的广泛和长期目标是体现在2009年的主题中,就是将“Everyday”与“Maybe Someday”融为一体。开发防御措施,特别是医疗对策或检测系统来应对生物或化学威胁,面临着许多挑战。本次会议将重点讨论一系列主题,其中新研究重点关注广谱和平台技术方法,以发现和开发利用和集成“日常”应用的生物和化学威胁防御措施。这次会议的具体目标是召集总共 135 名与会者,其中预计将有 54 名发言人,代表新的关键研究领域,这些领域是实现新方法“飞跃”所需的。将化学或生物恐怖主义对健康影响的准备工作与医学、公共卫生和严重环境危害的“日常”技术和系统结合起来。该计划将举行一次主题演讲会议和八场科学会议,讨论广谱治疗、诊断平台技术、化学和生物检测与通用平台的整合;宿主对生物和化学制剂的早期反应;转化研究:从动物到人; “灵丹妙药”:免疫调节剂和免疫增强剂;用于生物和化学试剂的“OMICS”;和筛选策略:干预的目标和机会。除了口头报告外,还将提供充足的海报会议机会。该应用的意义在于,戈登化学和生物恐怖主义防备研究会议为这个有点“利基”领域的过敏过程研究人员之间的密切互动和研究信息交流提供了独特的机会。该应用与健康的相关性在于,化学和生物恐怖主义防御研究的最终目标是为健康干预提供新的机会,无论是药物、疫苗、诊断还是检测系统,以帮助保护美国人民如果这些特工发生恐怖袭击。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MOLLY A HUGHES其他文献

MOLLY A HUGHES的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MOLLY A HUGHES', 18)}}的其他基金

A unique strategy for reshaping the antibiotics model: chemokine-inspired therapeutics for targeting the host and pathogen to counter infections caused by multidrug-resistant bacteria
重塑抗生素模型的独特策略:针对宿主和病原体的趋化因子启发疗法,对抗多重耐药细菌引起的感染
  • 批准号:
    10468194
  • 财政年份:
    2020
  • 资助金额:
    $ 1.5万
  • 项目类别:
A unique strategy for reshaping the antibiotics model: chemokine-inspired therapeutics for targeting the host and pathogen to counter infections caused by multidrug-resistant bacteria
重塑抗生素模型的独特策略:针对宿主和病原体的趋化因子启发疗法,对抗多重耐药细菌引起的感染
  • 批准号:
    10676878
  • 财政年份:
    2020
  • 资助金额:
    $ 1.5万
  • 项目类别:
A unique strategy for reshaping the antibiotics model: chemokine-inspired therapeutics for targeting the host and pathogen to counter infections caused by multidrug-resistant bacteria
重塑抗生素模型的独特策略:针对宿主和病原体的趋化因子启发疗法,对抗多重耐药细菌引起的感染
  • 批准号:
    10120102
  • 财政年份:
    2020
  • 资助金额:
    $ 1.5万
  • 项目类别:
A unique strategy for reshaping the antibiotics model: chemokine-inspired therapeutics for targeting the host and pathogen to counter infections caused by multidrug-resistant bacteria
重塑抗生素模型的独特策略:针对宿主和病原体的趋化因子启发疗法,对抗多重耐药细菌引起的感染
  • 批准号:
    10269939
  • 财政年份:
    2020
  • 资助金额:
    $ 1.5万
  • 项目类别:
Bacillus anthracis Targets Involved in Chemokine-Mediated Antimicrobial Activity
炭疽杆菌靶标参与趋化因子介导的抗菌活性
  • 批准号:
    8646871
  • 财政年份:
    2013
  • 资助金额:
    $ 1.5万
  • 项目类别:
Bacillus anthracis Targets Involved in Chemokine-Mediated Antimicrobial Activity
炭疽杆菌靶标参与趋化因子介导的抗菌活性
  • 批准号:
    8822201
  • 财政年份:
    2013
  • 资助金额:
    $ 1.5万
  • 项目类别:
Bacillus anthracis Targets Involved in Chemokine-Mediated Antimicrobial Activity
炭疽杆菌靶标参与趋化因子介导的抗菌活性
  • 批准号:
    8435665
  • 财政年份:
    2013
  • 资助金额:
    $ 1.5万
  • 项目类别:
Bacillus anthracis Targets Involved in Chemokine-Mediated Antimicrobial Activity
炭疽杆菌靶标参与趋化因子介导的抗菌活性
  • 批准号:
    9029273
  • 财政年份:
    2013
  • 资助金额:
    $ 1.5万
  • 项目类别:
2011 Chemical & Biological Terrorism Defense Gordon Research Conference (GRC) and
2011年化学
  • 批准号:
    8052353
  • 财政年份:
    2010
  • 资助金额:
    $ 1.5万
  • 项目类别:
Innate Immune Recognition of B. anthracis
炭疽芽孢杆菌的先天免疫识别
  • 批准号:
    7530781
  • 财政年份:
    2008
  • 资助金额:
    $ 1.5万
  • 项目类别:

相似国自然基金

时空序列驱动的神经形态视觉目标识别算法研究
  • 批准号:
    61906126
  • 批准年份:
    2019
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
  • 批准号:
    41901325
  • 批准年份:
    2019
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
  • 批准号:
    61802133
  • 批准年份:
    2018
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
  • 批准号:
    61802432
  • 批准年份:
    2018
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
  • 批准号:
    61872252
  • 批准年份:
    2018
  • 资助金额:
    64.0 万元
  • 项目类别:
    面上项目

相似海外基金

Heterogeneity and cellular hierarchy of lung cDC2
肺 cDC2 的异质性和细胞层次
  • 批准号:
    10665348
  • 财政年份:
    2023
  • 资助金额:
    $ 1.5万
  • 项目类别:
Dose escalation clinical trial of high-dose oral montelukast to inform future RCT in children with acute asthma exacerbations
大剂量口服孟鲁司特的剂量递增临床试验为哮喘急性发作儿童的未来随机对照试验提供信息
  • 批准号:
    10649012
  • 财政年份:
    2023
  • 资助金额:
    $ 1.5万
  • 项目类别:
The effects of wildfire exposure on maternal allergic asthma and consequences on neurobiology
野火暴露对母亲过敏性哮喘的影响及其对神经生物学的影响
  • 批准号:
    10727122
  • 财政年份:
    2023
  • 资助金额:
    $ 1.5万
  • 项目类别:
Double-Encapsulated mRNA Vaccine for COVID-19
适用于 COVID-19 的双囊 mRNA 疫苗
  • 批准号:
    10611763
  • 财政年份:
    2023
  • 资助金额:
    $ 1.5万
  • 项目类别:
Function and Differentiation
功能与差异化
  • 批准号:
    10886165
  • 财政年份:
    2023
  • 资助金额:
    $ 1.5万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了